Search
AbbVie Inc
ABBVAdd to Watchlist
216.490USD
-4.680-2.12%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
382.49BMarket Cap
106.56P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of AbbVie Inc is 7.94, ranking 90 out of 157 in the Pharmaceuticals industry. The average price target is 245.00, with a high of 289.00 and a low of 187.64.
Analyst Rating
Based on
34
analysts
Buy
Current Rating
253.229
Target Price
+14.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
AbbVie Inc
ABBV
34
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
Gilead Sciences Inc
GILD
33
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is AbbVie Inc's expected revenue for the next quarter?
AbbVie Inc's expected revenue is 16.76B.
What is AbbVie Inc's price target?
Analysts forecast that AbbVie Inc's price target is USD 245.00, with the highest forecast at USD 289.00 and the lowest forecast at USD 187.64.
How have AbbVie IncABBV's recent earnings per share performed?
The market expectation was USD 0.39, while AbbVie IncABBV's earnings per share (EPS) for the previous quarter was USD 1.02. EPS for the next quarter is expected at USD 3.77.
What is the analyst rating for AbbVie Inc?
Based on the ratings of AbbVie Inc's stock from 34 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
